Integrated Biopharma Performance

INBPDelisted Stock  USD 0.23  0.01  4.55%   
The company retains a Market Volatility (i.e., Beta) of -0.0082, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Integrated Biopharma are expected to decrease at a much lower rate. During the bear market, Integrated Biopharma is likely to outperform the market. Integrated Biopharma has an expected return of -0.25%. Please make sure to check out Integrated Biopharma maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Integrated Biopharma performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in May 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Begin Period Cash Flow210 K
Total Cashflows From Investing Activities-465 K

Integrated Biopharma Relative Risk vs. Return Landscape

If you would invest  25.00  in Integrated Biopharma on January 13, 2024 and sell it today you would lose (2.00) from holding Integrated Biopharma or give up 8.0% of portfolio value over 90 days. Integrated Biopharma is currently does not generate positive expected returns and assumes 5.8973% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of otc stocks are less volatile than Integrated, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
Given the investment horizon of 90 days Integrated Biopharma is expected to under-perform the market. In addition to that, the company is 9.97 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.21 per unit of volatility.

Integrated Biopharma Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Integrated Biopharma, and traders can use it to determine the average amount a Integrated Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0426

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsINBP

Estimated Market Risk

  actual daily
52% of assets are less volatile

Expected Return

  actual daily
Most of other assets have higher returns

Risk-Adjusted Return

  actual daily
Most of other assets perform better
Based on monthly moving average Integrated Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Biopharma by adding Integrated Biopharma to a well-diversified portfolio.

Integrated Biopharma Fundamentals Growth

Integrated OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Integrated Biopharma, and Integrated Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integrated OTC Stock performance.

About Integrated Biopharma Performance

To evaluate Integrated Biopharma OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Integrated Biopharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Integrated OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Integrated Biopharma market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Integrated's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.

Things to note about Integrated Biopharma performance evaluation

Checking the ongoing alerts about Integrated Biopharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Integrated Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Integrated Biopharma is not yet fully synchronised with the market data
Integrated Biopharma generated a negative expected return over the last 90 days
Integrated Biopharma has high historical volatility and very poor performance
Integrated Biopharma has some characteristics of a very speculative penny stock
Integrated Biopharma has a very high chance of going through financial distress in the upcoming years
About 69.0% of the company shares are held by company insiders
Evaluating Integrated Biopharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Integrated Biopharma's otc stock performance include:
  • Analyzing Integrated Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integrated Biopharma's stock is overvalued or undervalued compared to its peers.
  • Examining Integrated Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Integrated Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integrated Biopharma's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Integrated Biopharma's otc stock. These opinions can provide insight into Integrated Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Integrated Biopharma's otc stock performance is not an exact science, and many factors can impact Integrated Biopharma's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Integrated OTC Stock

If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format